Biotech M&A is heating up, and Mirum Pharmaceuticals stands out. Discover why analysts predict a 50% upside and long-term ...
US National Security Advisor Jake Sullivan is set to visit India early next week to take stock of the India-US Initiative on ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
After a decent first half, the drug and biotech sector saw a major downturn in the second half due to disappointing third-quarter sales and profits, guidance cuts, pipeline setbacks and the ...
Venture capital firms made approximately $52 billion in global investments in therapeutic-focused biotech companies between 2019 and 2021. Two-thirds of this sum was given to platform-tech start ...
For the end of this year, Fierce Biotech is taking the opportunity to reflect on trends emerging from 2024’s reporting. And readers have made it easy for us—it’s clear what kind of story ...
It was winner-takes-all in biotech investing in 2024. Larger funds attracted an outsize share of the available investment cash. While many companies struggled, dozens raised at least $100mn.
Syncromune, a biotech startup working on combination immunotherapies, has put together a $100 million Series A, the company told Endpoints News.
National Fuel Gas customers are going to see a significant increase in their natural gas bills beginning next month. The state Public Service Commission Thursday approved a rate agreement that ...
In August, a single email triggered a chain of hand-wringing and strategizing inside one of America’s largest medical technology companies: A reporter asked Boston Scientific if the biotech ...
But biotech stocks were hit even harder. For example, the S&P 500 dropped 3% yesterday and the Nasdaq 3.6%, but closely watched biotech index XBI was down nearly 5%, as was SPBIOS. The Nasdaq ...